Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 8/20 | 0.55 |
| ▸ | LPL | P06858 | 7/20 | 0.55 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | SNCA | P37840 | 1/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.38 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | P4HB | P07237 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALPL | P05186 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19106588 | 0.97 | LIPG (0.57) | LIPGLPLDGAT1NPC1RAB9A | |
| SCHEMBL19106587 | 0.93 | LIPG (0.62) | LIPGLPLDGAT1NPC1RAB9A | |
| SCHEMBL12424884 | 0.84 | LIPG (0.77) | LIPGLPLDGAT1SNCAP4HB | |
| SCHEMBL19794477 | 0.84 | LIPG (0.59) | LIPGLPLDGAT1SNCAPDGFRB | |
| SCHEMBL19106594 | 0.84 | LIPG (0.59) | LIPGLPLDGAT1SNCAPDGFRB | |
| SCHEMBL22639316 | 0.83 | LIPG (0.62) | LIPGLPLDGAT1SNCAPDGFRB | |
| SCHEMBL19106578 | 0.83 | LIPG (0.74) | LIPGLPLDGAT1NPC1RAB9A | |
| SCHEMBL23082128 | 0.83 | LIPG (0.80) | LIPGLPLDGAT1SNCAP4HB | |
| SCHEMBL17511943 | 0.83 | LIPG (0.80) | LIPGLPLDGAT1SNCAP4HB | |
| SCHEMBL23327826 | 0.83 | LIPG (0.80) | LIPGLPLDGAT1SNCAP4HB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10734588-B2 | Compound for organic electronic element, and organic electronic element and electronic device using same | DUK SAN NEOLUX CO., LTD (KR) | 2020-08-04 | — | — | US | disclosed |
| US-20170200903-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | DUK SAN NEOLUX CO., LTD. (KR) | 2017-07-13 | — | — | US | disclosed |
| US-20170200903-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | DUK SAN NEOLUX CO., LTD. (KR) | 2017-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170200903-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | NFE2L2, ESR1, VDAC2 | LIPG 2111/4885LPL 2245/4885DGAT1 374/4885 |
| US-10734588-B2 | Compound for organic electronic element, and organic electronic element and electronic device using same | NFE2L2, ESR1, VDAC2 | LIPG 2111/4885LPL 2245/4885DGAT1 374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.